Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Acute Lymphoblastic Leukemia HIGH RISK BCR / ABL NEGATIVE IN ADULTS

NCT01540812 is registered in ClinicalTrials.gov with PETHEMA Foundation as lead sponsor.

NCT NCT01540812
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01540812 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Acute Lymphoblastic Leukemia HIGH RISK BCR / ABL NEGATIVE IN ADULTS
Lead sponsor
PETHEMA Foundation
Phase
Observational
Overall status
Completed
Start date
February 29, 2012
Completion date
December 1, 2019
Enrollment
418 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia